Fubon NASDAQ-100 ETF (00662)

Overview

Genomtec S.A. is at the cutting edge of molecular diagnostics, holding a significant position both within its home country of Poland and on the international stage. Since its inception in 2016, the company has been pioneering in the field of diagnostics through its innovative development, manufacture, and commercialization of optical systems and isothermal nucleic acid amplification technologies. Through its efforts, Genomtec aims to make genetic diagnosis more mobile and accessible, leveraging their proprietary streamlined nucleic acid amplification technology (SNAAT) to facilitate quick and efficient detection of various pathogens and genetic mutations directly from patient samples such as swabs, urine, saliva, blood, and other bodily fluids. Based in Wroclaw, Poland, Genomtec S.A. continues to push the boundaries of what's possible in rapid, onsite molecular diagnostics, aiming to transform patient care worldwide.

Products and Services

• Genomtec ID

  Utilizing the streamlined nucleic acid amplification technology (SNAAT), Genomtec ID empowers healthcare professionals by providing mobile genetic diagnosis capabilities. This revolutionary device is capable of detecting viruses, bacteria, fungi, and genetic mutations by analyzing a wide range of biological materials directly from patients. Its portable nature and rapid results make it an invaluable tool in the fast-paced medical environment.

• Genomtec Tumor

  This is another SNAAT-based diagnostic solution, specifically designed to identify neoplastic mutations and mutations with prognostic value in cancers. Genomtec Tumor enables oncologists and pathologists to swiftly detect and characterize cancer mutations, thus facilitating personalized treatment plans and potentially improving patient outcomes.

• Genomtec SARS-CoV-2 EvaGreen

  Addressing the urgent need for effective COVID-19 testing solutions, the Genomtec SARS-CoV-2 EvaGreen kit is designed for the detection of SARS-CoV-2 RNA in various biological samples from patients with suspected COVID-19 infections. This tool is essential for healthcare providers in the timely and accurate diagnosis of COVID-19, aiding in the global fight against the pandemic.

• Direct-RT-LAMP CE-IVD Kit

  Complementing the SARS-CoV-2 EvaGreen toolkit, this diagnostic kit focuses on the detection of SARS-CoV-2 RNA through a direct RT-LAMP method. It's specially developed for a quick and reliable diagnosis of COVID-19 from a range of patient samples, playing a crucial role in the containment and management of the virus's spread.

• Genomtec RT-LAMP CE-IVD Duo-Kit

  Designed for comprehensive COVID-19 testing, the Duo-Kit facilitates the detection of all variants of the SARS-CoV-2 virus. It stands as a testament to Genomtec's commitment to adapt and respond to evolving diagnostic needs, especially in the face of a pandemic that sees the virus mutating frequently.